Header Logo

Connection

Magdalena Bieniasz to Phosphatidylinositol 3-Kinases

Back to Details
This is a "connection" page, showing publications Magdalena Bieniasz has written about Phosphatidylinositol 3-Kinases.
Magdalena Bieniasz
Connection Strength
0.115
Phosphatidylinositol 3-Kinases
  1. Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts. Clin Cancer Res. 2015 Dec 15; 21(24):5588-600.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.